
BackgroundTo assess prevalence and causes of vision loss in Central and South Asia.MethodsA systematic review of medical literature assessed the prevalence of blindness (presenting visual acuity<3/60 in the better eye), moderate and severe vision impairment (MSVI; presenting visual acuity <6/18 but ≥3/60) and mild vision impairment (MVI; presenting visual acuity <6/12 and ≥6/18) in Central and South Asia for 1990, 2010, 2015 and 2020.ResultsIn Central and South Asia combined, age-standardised prevalences of blindness, MSVI and MVI in 2015 were for men and women aged 50+years, 3.72% (80% uncertainty interval (UI): 1.39–6.75) and 4.00% (80% UI: 1.41–7.39), 16.33% (80% UI: 8.55–25.47) and 17.65% (80% UI: 9.00–27.62), 11.70% (80% UI: 4.70–20.32) and 12.25% (80% UI:4.86–21.30), respectively, with a significant decrease in the study period for both gender. In South Asia in 2015, 11.76 million individuals (32.65% of the global blindness figure) were blind and 61.19 million individuals (28.3% of the global total) had MSVI. From 1990 to 2015, cataract (accounting for 36.58% of all cases with blindness in 2015) was the most common cause of blindness, followed by undercorrected refractive error (36.43%), glaucoma (5.81%), age-related macular degeneration (2.44%), corneal diseases (2.43%), diabetic retinopathy (0.16%) and trachoma (0.04%). For MSVI in South Asia 2015, most common causes were undercorrected refractive error (accounting for 66.39% of all cases with MSVI), followed by cataract (23.62%), age-related macular degeneration (1.31%) and glaucoma (1.09%).ConclusionsOne-third of the global blind resided in South Asia in 2015, although the age-standardised prevalence of blindness and MSVI decreased significantly between 1990 and 2015.
macular degeneration, Asia, Vision Disorders, 610, Southeastern, vision loss expert group, Ophthalmology & Optometry, Blindness, 1117 Public Health and Health Services, WORLDWIDE, Risk Factors, vision impairment, Prevalence, Humans, VISUAL IMPAIRMENT, refractive error, Central, POPULATION, Asia, Southeastern, Science & Technology, GLOBAL PREVALENCE, vision loss, Southeastern/epidemiology, 1103 Clinical Sciences, Vision Loss Expert Group of the Global Burden of Disease Study, Central/epidemiology, RANIBIZUMAB, 1113 Opthalmology and Optometry, Ophthalmology, Vision Disorders/epidemiology, glaucoma, cataract, global burden of disease study, Asia, Central, epidemiology, blindness; cataract; epidemiology; glaucoma; global burden of disease study; macular degeneration; refractive error; vision impairment; vision loss; vision loss expert group; Ophthalmology; Sensory Systems; Cellular and Molecular Neuroscience, Blindness/epidemiology, Life Sciences & Biomedicine, Optometry, blindness
macular degeneration, Asia, Vision Disorders, 610, Southeastern, vision loss expert group, Ophthalmology & Optometry, Blindness, 1117 Public Health and Health Services, WORLDWIDE, Risk Factors, vision impairment, Prevalence, Humans, VISUAL IMPAIRMENT, refractive error, Central, POPULATION, Asia, Southeastern, Science & Technology, GLOBAL PREVALENCE, vision loss, Southeastern/epidemiology, 1103 Clinical Sciences, Vision Loss Expert Group of the Global Burden of Disease Study, Central/epidemiology, RANIBIZUMAB, 1113 Opthalmology and Optometry, Ophthalmology, Vision Disorders/epidemiology, glaucoma, cataract, global burden of disease study, Asia, Central, epidemiology, blindness; cataract; epidemiology; glaucoma; global burden of disease study; macular degeneration; refractive error; vision impairment; vision loss; vision loss expert group; Ophthalmology; Sensory Systems; Cellular and Molecular Neuroscience, Blindness/epidemiology, Life Sciences & Biomedicine, Optometry, blindness
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 55 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
